Please login to the form below
commentary
This page shows the latest commentary news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca takes home Company of the Year award at PMEA 2020
However, it’s just one element of our story which, as the PMEA judges remarked in their commentary on the night, has been driven by our company values, and these include
Latest news
-
Pharma Brand Planners' Blog (Part 7)
The answer to this question is an important commentary to add to your brand plan executive summary to inform senior management of the risks, volatility and uncertainty in your plan.
-
Gottlieb signs off with flair – and pledge of further drug price commentary
These remarks add to commentary Gottlieb made on the wider question of competition and drug prices last week at a Alliance for a Stronger FDA meeting last week.
-
A genomics and digital-led NHS is possible – but investment in staff essential
Read Harry Aagaard Evans' full Twitter commentary thread..
-
After December slump, what’s in store for biotech in 2019?
The conference generally sees a lot of new technology, data and deals announced and provides commentary on some of the top issues affecting the sector – such as declining R&D productivity,
-
Brexit to blame as firm plans to leave UK for Ireland
Commentary. The news of Steris’ plans for redomiciling were picked up yesterday by the staunchly anti-Brexit Evening Standard (its editor-in-chief being ex-Chancellor of the Exchequer George Osborne).
More from news
Approximately 1 fully matching, plus 43 partially matching documents found.
Latest Intelligence
-
Diversity and inclusion in clinical trials
If industry commentary is correct, sponsors want to drive this forward and this is likely to benefit patients and society as a whole.
-
Case study: Leading by example
The situation was compounded by a series of communications challenges. Media and political commentary highlighted the potential threats to the supply of life-saving medicines to the UK.
-
Is anybody listening?
Almost a decade ago, 80% of adult internet users looked online for health information, with a quarter relying on third-party commentaries and experiences expressed in personal blogs to inform decisions
-
Immunotherapy combination trials Q&A
Protocol review and commentary by regulatory agencies and patient advocacy helps to ensure the trial’s objectives are aligned from the outset with scientific merit as well as respect for the
-
The UK’s new five-year pricing agreement
to battle against the government plan to set the growth rate even lower (read Leslie’s commentary here).
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest appointments
-
Sanofi's Steve Oldfield to co-chair UK medicines access group
I am particularly interested in ensuring that the findings and recommendations from the National Metrics Report, and subsequent commentaries on it, result in robust action plans to address the barriers to
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
We must be candid about our use of healthcare data if we want to win back public trust
individual. One of the most disheartening things in much of the commentary is the failure to concede that the use of patient data, used safely and appropriately, is instrumental in helping
-
WHITE PAPER: What's missing in women's health?
https://www.who.int/life-course/news/commentaries/2015-intl-womens-day/. en/. Published 2016. Accessed March 5, 2020. 13. Pfizer update on Sayana Press shortages.
-
A masterclass in corporate communications
In an age in which so many authority figures in the public eye are evasive, ambiguous, or light on detail in their commentary, Soriot’s interview is notable for being none
-
Clinical trials and the diversity principle
of industry commentaries, or the peer-reviewed pages of PubMed.
-
September 2020: diversity and inclusion in clinical trials round-up
In a recent commentary in JCO Global Oncology, authors outlined the lung cancer disparities in Hispanics, both in and outside the US.
More from PMHub
Approximately 0 fully matching, plus 15 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- A new era for UK-Japanese scientific research relations
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- FDA issues innovative proposal to increase nonprescription drug access
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- My journey advancing the science in pulmonary hypertension
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
PMHub
Havas Life Medicom
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
